-
- 产品货号:
- M5831
-
- 中文名称:
- Octreotide Acetate
-
- 英文名称:
- Octreotide Acetate
-
- CAS号:
- 79517-01-4
-
- 品牌:
- Abmole
-
货号
产品规格
售价
备注
-
M5831-10mg
10mg
¥540.00
>98%
-
M5831-50mg
50mg
¥1080.00
>98%
产品描述
货号
产品规格
售价
备注
M5831-10mg
10mg
¥540.00
>98%
M5831-50mg
50mg
¥1080.00
>98%
产品描述
上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。
名称 | DOTA-[Tyr3]-Octreotide |
编码 | [177943-89-4] |
别名 | DOTA-[Tyr3]-Octreotide |
纯度 | 80%,90%,95%,98%,99% |
重量 | 1mg,5mg,10mg,50mg,100mg,1g |
序列(单字母缩写) | DOTA-fCYwKTCT-ol (C2&C7 bridge) |
序列(三字母缩写) | DOTA-DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (trifluoroacetate salt)(Cys2 and 7 bridge) |
基本描述 | This NYAD-2 peptide is NYAD-1 labeled with FITC (Ex/Em=493/517 nm). NYAD-1 is a cell-penetrating alphalpha-Helical peptide used as a potential HIV-1 inhibitor. The hydrocarbon-stapled structure enhances alpha helicity. |
溶解度 | |
分子量 | 1421.64 |
化学式 | C65H90N14O19S2 |
存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
注释 | |
Documents | |
Figures | |
Reference | L.Kolby et al., Br. J. Cancer, 93, 1144 (2005) R.Valkema et al., J. Nucl. Med., 46, 83S (2005) M.de Jong et al., J. Nucl. Med., 46, 13S (2005) W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003) A.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003) Chinol, M. et al. Semin. Nucl. Med. 32,141(2002) De Jong, M. et al. semin Nucl. Med. 32,133(2002) |
C端 | |
N端 | |
化学桥 | (Cys2 and 7 bridge) |
上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。
名称 | DOTA-Octreotide |
编码 | |
别名 | DOTA-Octreotide |
纯度 | 80%,90%,95%,98%,99% |
重量 | 1mg,5mg,10mg,50mg,100mg,1g |
序列(单字母缩写) | DOTA-fCFwKTCT-ol (C2&C7 bridge) |
序列(三字母缩写) | DOTA-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol (trifluoroacetate salt)(Cys2 and 7 bridge) |
基本描述 | |
溶解度 | |
分子量 | 1405.7 |
化学式 | C65H92N14O17S2 |
存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
注释 | |
Documents | |
Figures | |
Reference | L.Kolby et al., Br. J. Cancer, 93, 1144 (2005) R.Valkema et al., J. Nucl. Med., 46, 83S (2005) M.de Jong et al., J. Nucl. Med., 46, 13S (2005) W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003) A.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003) Chinol, M. et al. Semin. Nucl. Med. 32,141(2002) |
C端 | |
N端 | |
化学桥 | (Cys2 and 7 bridge) |
上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。
名称 | Octreotide (SMS 201-995) |
编码 | [79517-01-4] |
别名 | Octreotide (SMS 201-995) |
纯度 | 80%,90%,95%,98%,99% |
重量 | 1mg,5mg,10mg,50mg,100mg,1g |
序列(单字母缩写) | fCFwKTCT-ol (C2&C7 bridge) |
序列(三字母缩写) | H-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol (trifluoroacetate salt)(Cys2 and 7 bridge) |
基本描述 | [Cys2, Tyr3,Orn5,Pen7]. This somatostatin analog is a very potent and highly selective ligand for m-opioid receptors. |
溶解度 | |
分子量 | 1019.2 |
化学式 | C48H66N10O9S2 |
存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
注释 | |
Documents | |
Figures | |
Reference | S.Grozinsky-Glasberg et al., Neuroendocrinology, 87, 168 (2008) T.E.Jonassen et al., Am. J. Physiol. Renal Physiol., 291, F537 (2006) H.G.Ding et al., Chin. Med. J., 117, 913 (2004) G.Melacini et al., Biochemistry, 36, 1233 (1997) S.W.Lamberts et al., N. Engl. J. Med., 334, 246 (1996) D. Maouyo et al., Pancreas, 14, 47 (1997) W. Bauer et al., Life Sci, 31(11), 1133 (1982) |
C端 | |
N端 | |
化学桥 | (Cys2 and 7 bridge) |
上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。
名称 | Octreotide Acetate |
编码 | [79517-01-4] |
别名 | Octreotide Acetate |
纯度 | 80%,90%,95%,98%,99% |
重量 | 1mg,5mg,10mg,50mg,100mg,1g |
序列(单字母缩写) | fCFwKTCTOL[Cys2-Cys7 bridge] |
序列(三字母缩写) | D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-Ol(Cys2-Cys7 bridge) |
基本描述 | |
溶解度 | |
分子量 | 1019.2 |
化学式 | C49H66N10O10S2 |
存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
注释 | |
Documents | |
Figures | |
Reference | |
C端 | |
N端 | |
化学桥 | (Cys2-Cys7 bridge) |